Vera Therapeutics (VERA)

• Market cap: $3.59B
• 1 day: -1.04%
• 5 days: -6.81%
• 1 month: 53.45%
• 3 months: 74.26%
• 6 months: 114.94%
• Year to date: 20%
• 1 year: 19.74%
• 5 years: 340.35%
• 10 years: 340.35%
• Sector: Healthcare
• Industry: Biotechnology

About: Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Employees: 224